Pairing parents and offspring's HemoTypeSC Test to validate results and confirm sickle cell pedigree:  a case study in Kisangani, the Democratic Republic of the Congo

References

• Oluwole EO, Adeyemo TA, Osanyin GE, et al. Feasibility and acceptability of early infant screening for sickle cell disease in Lagos, Nigeria – a pilot study. PLoS ONE. 2020;15(12):e0242861. DOI:10.1371/journal.pone.0242861
   PubMed Web of Science ®Google Scholar
• Mukherjee MB, Colah RB, Mehta PR, et al. Multicenter evaluation of HemoTypeSC as a point-of-care sickle cell disease rapid diagnostic test for newborns and adults across India. Am J Clin Pathol. 2020;153(1):82–87. DOI: 10.1093/ajcp/aqz108
   PubMed Web of Science ®Google Scholar
• McGann PT, Schaefer BA, Paniagua M, et al. Characteristics of a rapid, point-of-care lateral flow immunoassay for the diagnosis of sickle cell disease. Am J Hematol. 2016;91:205–210. DOI:10.1002/ajh.24232
   PubMed Web of Science ®Google Scholar
• Mulumba LL, Wilson L. Sickle cell disease among children in Africa: an integrative literature review and global recommendations. Int J Africa Nurs Sci. 2015;3:56–64. DOI:10.1016/j.ijans.2015.08.002
   Google Scholar
• Nnodu OE, Sopekan A, Nnebe-Agumadu U, et al. Implementing newborn screening for sickle cell disease as part of immunization programmes in Nigeria: a feasibility study. Lancet Haematol. 2020;7:e534–e540.
   PubMed Web of Science ®Google Scholar
• Hsu L, Nnodu OE, Brown BJ, et al. White paper: pathways to progress in newborn screening for sickle cell disease in sub-Saharan Africa. J Trop Dis. 2018;6:260. DOI:10.4172/2329-891X.1000260
   Google Scholar
• McGann PT. Time to invest in sickle cell anemia as a global health priority. Pediatrics. 2016;137(6):e20160348. DOI:10.1542/peds.2016-0348
   PubMed Web of Science ®Google Scholar
• Kasaï ET, Opara JPA, Agasa SB, et al. Acceptabilité du Dépistage néonatal de la drépanocytose au cours de la Pandémie au Covid-19 à Kisangani, en République Démocratique du Congo. Pan African J Med. 2020;37:299. DOI:10.11604/pamj.2020.37.299.26654
   PubMedGoogle Scholar
• Aloni MN, Kadima BT, Ekulu PM, et al. Acute crises and complications of sickle cell anemia among patients attending a pediatric tertiary unit in Kinshasa, Democratic Republic of Congo. Hematol Rep. 2017;9(2):6952. DOI:10.4081/hr.2017.6952
   PubMed Web of Science ®Google Scholar
• Tshilolo L, Aissi LM, Lukusa D, et al. Neonatal screening for sickle cell anaemia in the Democratic Republic of the Congo: experience from a pioneer project on 31 204 newborns. J Clin Pathol. 2009;62:35–38. DOI:10.1136/jcp.2008.058958
   PubMed Web of Science ®Google Scholar
• Balédent F. Génétique et biologie de la drépanocytose. France. Santé et Développement, n°. 2006;182. [Cited 2022 January 3]. Available from: https://devsante.org/articles/genetique-et-biologie-de-la-drepanocytose
   Google Scholar
• Ojodu J, Hulihan MM, Pope SN, et al. Incidence of sickle cell trait – United States, 2010. Morb Mortal Wkly Rep. 2014;63(49):1155–1158.
   PubMed Web of Science ®Google Scholar
• Kasai ET, Opara JPA, Kadima JN, et al. Overview of current progress and challenges in diagnosis, and management of pediatric sickle cell disease in democratic republic of the Congo. Hematology. 2022;27(1):132–140. DOI:10.1080/16078454.2021.2023399
   PubMed Web of Science ®Google Scholar
• Olatunya OS, Babatola AO, Ogundare EO, et al. Perceptions and practice of early diagnosis of sickle cell disease by parents and physicians in a southwestern state of Nigeria. Scientific World J. 2020; ID 4801087, 7 pages. DOI:10.1155/2020/4801087
   Google Scholar
• Steele C, Sinski A, Asibey J, et al. Point-of-care screening for sickle-cell disease in low-resource settings: a multi-center evaluation of HemoTypeSC, a Novel Rapid Test. Am J Hematol. 2018: 1–7. DOI:10.1002/ajh.25305
   Web of Science ®Google Scholar
• Olatunya OS, Albuquerque DM, Fagbamigbe AF, et al. Diagnostic accuracy of HemoTypeSC as a point-of-care testing device for sickle cell disease: findings from a southwestern state in Nigeria and implications for patient care in resource poor settings of sub-Saharan Africa. Glob Pediatr Health. 2021;8:1–10. DOI:10.1177/2333794X211016789
   Google Scholar
• Tshilolo L, Kafando E, Sawadogo M, et al. Neonatal screening and clinical care programmes for sickle cell disorders in sub-Saharan Africa: lesson for pilot studies. Public Health. 2008;122(9):933–941. DOI:10.1016/j.puhe.2007.12.005
   PubMed Web of Science ®Google Scholar
• Bond M, Hunt B, Flynn B, et al. Towards a point-of-care strip test to diagnose sickle cell anemia. PLoS ONE. 2017;12(5):e0177732. [Cited 2022 January 11]. Available from: doi:10.1371/journal.pone.0177732
   PubMed Web of Science ®Google Scholar
• Kasaï ET, Boemer F, Djang’eing’a RM, et al. Systematic screening of neo- natal sickle cell disease with HemoTypeSC Kit-Test: case study and literature review. Open J Blood Dis. 2020;10:12–21. DOI:10.4236/2Fojbd.2020.101002
   Google Scholar
• Abdala AK, Shongo MYP, Tshilolo LMM, et al. Place de l’HemoTypeSC dans le dépistage de la drépanocytose à Kindu, République Démocratique du Congo. Revue de l’Infirmier Congolais. 2021;5(1):51–55.
   Google Scholar
• Mbiya BM. Suivi clinique, hématologique et identification de la fréquence des indications d’un traitement par hydroxy urée chez les patients drépanocytaires dans une ville reculée d’un pays à faibles ressources [Thèse]. Bruxelles: Université Libre de Bruxelles-Faculté de Médecine; 2021.
   Google Scholar
• Luboya E, Tshilonda JCB, Ekila MB, et al. Répercussions psychosociales de la drépanocytose sur les parents d’enfants vivant à Kinshasa, République Démocratique du Congo: une étude qualitative. Pan Afr Med J. 2014;19(5). DOI:10.11604/pamj.2014.19.5.2830
   Google Scholar
• Wikimédia Commons. Religion en république démocratique du Congo, 2021. [cited 2022 January 20]. Available from: https://fr.wikipedia.org/wiki/Religion_en_r%C3%A9publique_d%C3%A9mocratique_du_Congo
   Google Scholar
• Danho JBK, Atiméré YN, Koné D, et al. Feasibility study of the ‘HemoTypeSC’ test for the rapid screening of sickle cell disease in Côte D’Ivoire. Adv Hematol. 2021;2021:17. DOI:10.1155/2021/8862039
   Google Scholar
• Couque N, De Montalembert M. Diagnostic d’une hémoglobinopathie. Hématologie, Hémoglobinopathie; Feuillets de Biologie. 2013;54(311):5–18.
   Google Scholar
• Agasa B, Bosunga K, Opara A, et al. Prevalence of sickle cell disease in a northeastern region of the Democratic Republic of Congo: what impact on transfusion policy? British Blood Transfusion Society, Transfusion Medicine. 2010;20:62–65. DOI:10.1111/j.1365-3148.2009.00943.x
   Web of Science ®Google Scholar
• Kambale-Kombi P, Djang’eing’a RM, Opara JPA, et al. Students’ knowledge on sickle cell disease in Kisangani, Democratic Republic of the Congo. Hematology. 2020;25(1):91–94. DOI:10.1080/16078454.2020.1727174
   PubMed Web of Science ®Google Scholar
• Mandu K, Tusuubira SK, Mwambi B, et al. To test or not: occurrence of sickle cell trait and assessment of the awareness toward its screening among patients attending Magale health center iV, namisindwa District, eastern Uganda. J Blood Med. 2018;9:219–225. DOI:10.2147/JBM.S177203
   PubMed Web of Science ®Google Scholar